Kyverna Therapeutics, Inc. SEC Filing

KYTX filed a Form 144 reporting the proposed sale of 17,578 shares of Common Stock via a stock option exercise to be effected on 04/07/2026 for cash.

Rhea-AI Filing Summary

KYTX filed a Form 144 reporting the proposed sale of 17,578 shares of Common Stock via a stock option exercise to be effected on 04/07/2026 for cash. The filing also discloses a prior sale of 16,634 shares on 03/31/2026 for $140,404.27.

Key Figures

Proposed shares to be sold: 17,578 shares Reported value associated: $162,636.93 Prior sale - shares: 16,634 shares +1 more

4 metrics

Proposed shares to be sold 17,578 shares stock option exercise scheduled 04/07/2026

Reported value associated $162,636.93 listed alongside 17,578 shares on 04/07/2026 row

Prior sale - shares 16,634 shares sold by Daniel Spiegelman on 03/31/2026

Prior sale - proceeds $140,404.27 proceeds reported for 16,634-share sale on 03/31/2026

Key Terms

Form 144, Stock Option Exercise, Issuer, Cash

4 terms

Form 144 regulatory

"144: Securities To Be Sold"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Stock Option Exercise financial

"Common | 04/07/2026 | Stock Option Exercise"

A stock option exercise is the act of using a previously granted right to buy shares of a company's stock at a specific, predetermined price by paying that price and receiving the shares. It matters to investors because exercising changes who owns the shares (which can dilute existing ownership), can trigger taxable events and shift potential gains or losses, and affects voting power and the company’s outstanding share count—like turning a voucher into an actual product that becomes part of circulating supply.

Issuer financial

"Stock Option Exercise | Issuer"

Cash financial

"04/07/2026 | Cash"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/07/2026 - 04:05 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001238403
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	KYVERNA THERAPEUTICS, INC.
SEC File Number	001-41947
Address of Issuer	5980 Horton St., STE 550 Emeryville, CALIFORNIA 94608
Phone	(510) 925-2492
Name of Person for Whose Account the Securities are To Be Sold	DANIEL SPIEGELMAN
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	17578	162636.93	60439893	04/07/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	04/07/2026	Stock Option Exercise	Issuer			17578	04/07/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
DANIEL SPIEGELMAN 5980 Horton St., STE 550 Emeryville, CA 94608	Common	03/31/2026	16634	140404.27

144: Remarks and Signature

Remarks
Date of Notice	04/07/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Dan Spiegelman
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)